Body fluid samples were collected for early cancer detection, and CTC, ctDNA and other markers were captured to evaluate the tumor situation. It is non-invasive, efficient, sensitive and highly acceptable for patients.

According to Researcher's new survey, global Early Cancer Detection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Early Cancer Detection market research.

The early cancer detection market is a rapidly evolving sector within the healthcare industry. Early detection of cancer is crucial for improving treatment outcomes and reducing mortality rates. Detecting cancer at an earlier stage allows for more effective treatment options and increases the chances of successful recovery.

Various screening technologies are used for early cancer detection, including imaging techniques like mammography for breast cancer, colonoscopy for colorectal cancer, Pap smear for cervical cancer, and PSA blood test for prostate cancer. These screening methods have been widely adopted and are proven to be effective in detecting cancer at an early stage.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Early Cancer Detection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.


By Company


GRAIL(Illumina)

Exact Sciences

Guardant Health

BGI

New Horizon Health

Epigenomics AG

Genetron Health

Berry Genomics


Segment by Type


ctDNA

CTC

Exosomes

Circulating protein


Segment by Application


Hospital

Clinic

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The Early Cancer Detection report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source